🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study will evaluate the safety and efficacy of inavolisib combination ...
Status
Recruiting
Location
Los Angeles Cancer Network
Start Date
2025-09-09
Trial ID
NCT07054190
Treatments Being Tested
This proof of concept study is designed to evaluate the efficacy and safety...
Status
Terminated
Location
Addenbrookes Hospital
Start Date
2008-03
Trial ID
NCT00542269
Treatments Being Tested
The goal of this research study is to evaluate the safety and feasibility o...
Status
Withdrawn
Location
Multiple Locations
Start Date
2023-05
Trial ID
NCT05774886
Treatments Being Tested
Drugs used in chemotherapy use different ways to stop tumor cells from divi...
Status
Completed
Location
Gynecologic Oncology Group
Start Date
2001-01
Trial ID
NCT00011986
The goal of this open-label randomised, controlled, non-inferiority trial i...
Status
Recruiting
Location
Ruhuha Health Centre
Start Date
2025-09-11
Trial ID
NCT05951595
This Study Was Made to Evaluate the Antibacterial Effect of Different Antib...
Status
Completed
Location
Multiple Locations
Start Date
2015-01-16
Trial ID
NCT03533231
The differential diagnosis of asthma and COPD is sometimes difficult. Recen...
Status
Unknown
Location
UZ Gasthuisberg
Start Date
2015-07
Trial ID
NCT02488590
Treatments Being Tested
Melasma relapse is almost common after discontinuation of conventional trea...
Status
Completed
Location
Ajou University Hospital
Start Date
2021-12-01
Trial ID
NCT05710068
Treatments Being Tested
Assess the efficacy and safety of the topic use of an eutectic mixture of l...
Status
Unknown
Location
Clínica Reis Neto
Start Date
2010-04
Trial ID
NCT00932542
Treatments Being Tested
The primary purpose of this study is to evaluate lung function and health r...
Status
Completed
Location
GSK Investigational Site
Start Date
2018-06-25
Trial ID
NCT03478696